NO20005887L - Forbindelser med IgE-påvirkende egenskaper - Google Patents

Forbindelser med IgE-påvirkende egenskaper

Info

Publication number
NO20005887L
NO20005887L NO20005887A NO20005887A NO20005887L NO 20005887 L NO20005887 L NO 20005887L NO 20005887 A NO20005887 A NO 20005887A NO 20005887 A NO20005887 A NO 20005887A NO 20005887 L NO20005887 L NO 20005887L
Authority
NO
Norway
Prior art keywords
ige
compounds
affecting properties
affecting
properties
Prior art date
Application number
NO20005887A
Other languages
English (en)
Other versions
NO20005887D0 (no
Inventor
Jagadish Sircar
Mark L Richards
Michael G Campbell
Michael W Major
Original Assignee
Avanir Pharmaceuticals
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=22198947&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NO20005887(L) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Avanir Pharmaceuticals filed Critical Avanir Pharmaceuticals
Publication of NO20005887D0 publication Critical patent/NO20005887D0/no
Publication of NO20005887L publication Critical patent/NO20005887L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A61K31/4184—1,3-Diazoles condensed with carbocyclic rings, e.g. benzimidazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
    • A61K31/4545—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a six-membered ring with nitrogen as a ring hetero atom, e.g. pipamperone, anabasine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
NO20005887A 1998-05-22 2000-11-21 Forbindelser med IgE-påvirkende egenskaper NO20005887L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US8649498P 1998-05-22 1998-05-22
PCT/US1999/011363 WO1999061013A2 (en) 1998-05-22 1999-05-21 COMPOUNDS HAVING IgE AFFECTING PROPERTIES

Publications (2)

Publication Number Publication Date
NO20005887D0 NO20005887D0 (no) 2000-11-21
NO20005887L true NO20005887L (no) 2001-01-19

Family

ID=22198947

Family Applications (3)

Application Number Title Priority Date Filing Date
NO20005888A NO20005888L (no) 1998-05-22 2000-11-21 Benzimidazolderivater som mudulatorer av IgE
NO20005889A NO20005889L (no) 1998-05-22 2000-11-21 Benzimidazolderivater som ned-regulatorer av IgE
NO20005887A NO20005887L (no) 1998-05-22 2000-11-21 Forbindelser med IgE-påvirkende egenskaper

Family Applications Before (2)

Application Number Title Priority Date Filing Date
NO20005888A NO20005888L (no) 1998-05-22 2000-11-21 Benzimidazolderivater som mudulatorer av IgE
NO20005889A NO20005889L (no) 1998-05-22 2000-11-21 Benzimidazolderivater som ned-regulatorer av IgE

Country Status (22)

Country Link
US (2) US6271390B1 (no)
EP (3) EP1079830A1 (no)
JP (3) JP2002516277A (no)
KR (1) KR100591652B1 (no)
CN (4) CN1311675A (no)
AT (1) ATE292465T1 (no)
AU (3) AU754562B2 (no)
BR (3) BR9910642A (no)
CA (3) CA2332985A1 (no)
CZ (2) CZ20004350A3 (no)
DE (1) DE69924607T2 (no)
ES (1) ES2241285T3 (no)
HU (3) HUP0101894A3 (no)
IL (3) IL139827A0 (no)
MX (3) MXPA00011422A (no)
NO (3) NO20005888L (no)
NZ (2) NZ508416A (no)
PL (3) PL345952A1 (no)
RU (2) RU2236220C2 (no)
UA (2) UA67775C2 (no)
WO (3) WO1999061013A2 (no)
ZA (3) ZA200007754B (no)

Families Citing this family (56)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6911462B2 (en) * 1998-05-22 2005-06-28 Avanir Pharmaceuticals Benzimidazole compounds for regulating IgE
US6919366B2 (en) 1998-05-22 2005-07-19 Avanir Pharmaceuticals Benzimidazole derivatives as modulators of IgE
CZ20004350A3 (cs) * 1998-05-22 2002-02-13 Avanir Pharmaceuticals Benzimidazolové deriváty jako modulátory IgE
RU2001106631A (ru) * 1998-09-11 2004-03-20 Адзиномото Ко., Инк. (Jp) Производные бензола и их фармацевтическое применение
US6270746B1 (en) * 1999-02-17 2001-08-07 David H. Katz Assay for the identification of IgE antibody suppressors
DK1173169T3 (da) * 1999-03-26 2010-08-23 Euro Celtique Sa Arylsubstituerede pyrazoler, imidazoler, oxazoler, thiazoler og pyrroler og anvendelsen deraf
AU5570600A (en) * 1999-07-01 2001-01-22 Ajinomoto Co., Inc. Heterocyclic compounds and medicinal use thereof
AU6866700A (en) * 1999-09-01 2001-03-26 Ajinomoto Co., Inc. Biscyclopropanecarboxylic acid amide compounds and medicinal use thereof
US6759425B2 (en) 1999-10-21 2004-07-06 Avanir Pharmaceuticals Benzimidazole compounds for modulating IgE and inhibiting cellular proliferation
US6448281B1 (en) 2000-07-06 2002-09-10 Boehringer Ingelheim (Canada) Ltd. Viral polymerase inhibitors
US20070208087A1 (en) 2001-11-02 2007-09-06 Sanders Virginia J Compounds, compositions and methods for the treatment of inflammatory diseases
DK1368028T3 (da) * 2001-03-12 2007-12-27 Avanir Pharmaceuticals Benzimidazolforbindelser til IgE-modulering og inhibering af cellulær profi-ferering
CN1638765A (zh) 2001-07-27 2005-07-13 柯里斯公司 Hedgehog信号转导途径介质、其相关组合物以及应用
RS50939B (sr) 2001-10-19 2010-08-31 Ortho-Mcneil Pharmaceutical Inc. 2-fenil benzimidazoli i imidazo-/4,5/-piridini kao cdsi/chk2 -inhibitori i pomoćna sredstva u hemoterapiji ili terapiji zračenja pri lečenju kancera
US20030157555A1 (en) * 2002-01-14 2003-08-21 Lipps Binie V. Diagnosis and treatment for immunoglobulin E ( IgE) implicated disorders
US20080081788A1 (en) * 2002-01-14 2008-04-03 Lipps Binie V Diagnosis and treatment for immunoglobulin E (IgE) implicated disorders
TW200304820A (en) * 2002-03-25 2003-10-16 Avanir Pharmaceuticals Use of benzimidazole analogs in the treatment of cell proliferation
DK1511710T3 (en) 2002-05-31 2014-02-24 Proteotech Inc RELATIONSHIPS, PREPARATIONS AND METHODS FOR TREATING AMYLOID DISEASES AND SYNUCLEINOPATHES, SUCH AS ALZHEIMER'S DISEASE, TYPE 2-DIABETES AND PARKINSON'S DISEASE
EP1388535A1 (en) 2002-08-07 2004-02-11 Aventis Pharma Deutschland GmbH Acylated arylcycloalkylamines and their use as pharmaceuticals
EP2371389A3 (en) 2002-08-14 2012-04-18 MacroGenics, Inc. FcgammaRIIB-specific antibodies and methods of use thereof
WO2004024655A2 (en) 2002-09-12 2004-03-25 Avanir Pharmaceuticals Phenyl-indole compounds for modulating ige and inhibiting cellular proliferation
TWI276631B (en) * 2002-09-12 2007-03-21 Avanir Pharmaceuticals Phenyl-aza-benzimidazole compounds for modulating IgE and inhibiting cellular proliferation
US20050239844A1 (en) * 2002-11-02 2005-10-27 Kyung-Lim Lee Composition fo preventing secretion of immunoglobulin e-dependent histamine releasing factor
GB2397301A (en) * 2003-01-14 2004-07-21 Novo Pharmaceuticals Ltd De Substituted 1,3,5-triazine derivatives
EP1613313B1 (en) 2003-04-17 2007-06-06 Janssen Pharmaceutica N.V. 2-phenyl-benzimidazol and 2-phenyl-imidazo-4,5]-pyridine derivatives as checkpoint kinase cds1 (chk2) inhibitors for the treatment of cancer
WO2005013950A2 (en) * 2003-08-08 2005-02-17 Avanir Pharmaceuticals Selective pharmacologic inhibition of protein trafficking and related methods of treating human diseases
CN102911161A (zh) 2004-02-20 2013-02-06 贝林格尔.英格海姆国际有限公司 病毒聚合酶抑制剂
EP1751097B1 (en) * 2004-05-12 2009-12-30 Proteotech, Inc. Substituted n-aryl benzamides and related compounds for treatment of amyloid diseases and synucleinopathies
US7250427B2 (en) 2004-06-30 2007-07-31 Janssen Pharmaceutica, N.V. Aryl-substituted benzimidazole and imidazopyridine ethers
WO2006040645A1 (en) * 2004-10-11 2006-04-20 Ranbaxy Laboratories Limited N-(3,5-dichloropyridin-4-yl)-2,4,5-alkoxy and 2,3,4-alkoxy benzamide derivatives as pde-iv (phophodiesterase type-iv) inhibitors for the treatment of inflammatory diseases such as asthma
EP1954287B2 (en) † 2005-10-31 2016-02-24 Merck Sharp & Dohme Corp. Cetp inhibitors
EP1790345A1 (en) * 2005-11-02 2007-05-30 Esbatech AG Triazin beta-secretase inhibitors
US7671221B2 (en) * 2005-12-28 2010-03-02 Vertex Pharmaceuticals Incorporated Modulators of ATP-Binding Cassette transporters
AU2006336504C9 (en) * 2005-12-28 2015-05-14 Vertex Pharmaceuticals Incorporated 1-(benzo [D] [1,3] dioxol-5-yl) -N- (phenyl) cyclopropane- carboxamide derivatives and related compounds as modulators of ATP-Binding Cassette transporters for the treatment of Cystic Fibrosis
EP2505209A1 (en) 2006-06-26 2012-10-03 MacroGenics, Inc. Fcgamma-RIIB-specific antibodies and methods of the use thereof
US20100112606A1 (en) * 2008-10-17 2010-05-06 Michael Armstrong Measurement and analysis of leukotrienes
EP2367823A1 (en) 2008-12-23 2011-09-28 Abbott Laboratories Anti-viral compounds
US8541424B2 (en) 2008-12-23 2013-09-24 Abbott Laboratories Anti-viral compounds
WO2010120935A1 (en) 2009-04-15 2010-10-21 Abbott Laboratories Anti-viral compounds
US8937150B2 (en) 2009-06-11 2015-01-20 Abbvie Inc. Anti-viral compounds
US8716454B2 (en) 2009-06-11 2014-05-06 Abbvie Inc. Solid compositions
DK2628481T3 (en) 2009-06-11 2016-06-06 Abbvie Bahamas Ltd Tri-substituted heterocycles AS INHIBITORS OF HEPATITIS C VIRUS (HCV) replication
US9394279B2 (en) 2009-06-11 2016-07-19 Abbvie Inc. Anti-viral compounds
EP2509975B1 (en) * 2009-12-04 2014-04-23 Boehringer Ingelheim International GmbH Benzimidazole inhibitors of leukotriene production
NZ605440A (en) 2010-06-10 2014-05-30 Abbvie Bahamas Ltd Solid compositions comprising an hcv inhibitor
NZ606660A (en) * 2010-07-20 2014-11-28 Vestaron Corp Insecticidal triazines and pyrimidines
US8829200B2 (en) 2010-10-29 2014-09-09 Boehringer Ingelheim International Gmbh Benzimidazole inhibitors of leukotriene production
JP5789888B2 (ja) 2010-11-01 2015-10-07 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング ロイコトリエン生成のベンゾイミダゾールインヒビター
US10201584B1 (en) 2011-05-17 2019-02-12 Abbvie Inc. Compositions and methods for treating HCV
US9034832B2 (en) 2011-12-29 2015-05-19 Abbvie Inc. Solid compositions
US11484534B2 (en) 2013-03-14 2022-11-01 Abbvie Inc. Methods for treating HCV
EP3089757A1 (en) 2014-01-03 2016-11-09 AbbVie Inc. Solid antiviral dosage forms
WO2019018562A1 (en) 2017-07-19 2019-01-24 Ideaya Biosciences, Inc. AMIDO COMPOUND AS MODULATORS OF AHR
KR20210061377A (ko) * 2018-09-18 2021-05-27 테른스, 인크. 특정 백혈병을 치료하기 위한 화합물
CN110054558B (zh) * 2019-05-16 2022-03-25 海门瑞一医药科技有限公司 一种1-三氟甲基环丙烷-1-甲酸的制备方法
CN112441983B (zh) * 2019-08-29 2023-09-15 山东福长药业有限公司 一种基于苯并咪唑取代的硝基苯的化合物及其制备方法

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3017610A (en) * 1957-03-15 1962-01-16 Curtiss Wright Corp Electronic data file processor
US4939133A (en) * 1985-10-01 1990-07-03 Warner-Lambert Company N-substituted-2-hydroxy-α-oxo-benzeneacetamides and pharmaceutical compositions having activity as modulators of the arachidonic acid cascade
LU86258A1 (fr) 1986-01-21 1987-09-03 Rech Dermatologiques C I R D S Composes benzamido aromatique,leur procede de preparation et leur utilisation en medecine humaine ou veterinaire et en cosmetique
US4744026A (en) * 1986-04-11 1988-05-10 American Telephone And Telegraph Company, At&T Bell Laboratories Methods and apparatus for efficient resource allocation
IT1232252B (it) * 1989-02-22 1992-01-28 Rotta Research Lab Derivati della n fenil benzamide ad attivita' antiulcera ed antiallerica e procedimento per la loro preparazione
EP0428939B1 (de) * 1989-11-21 1996-01-17 Bayer Ag Cumarinderivate, Verfahren zu ihrer Herstellung, ihre Verwendung und Thiazolyl-essigsäurederivate als Zwischenprodukte
ATE128030T1 (de) * 1990-08-02 1995-10-15 Hoffmann La Roche Antiallergische mischung.
IE71647B1 (en) * 1991-01-28 1997-02-26 Rhone Poulenc Rorer Ltd Benzamide derivatives
JP3634861B2 (ja) * 1992-06-15 2005-03-30 セルテック リミテッド 選択的ホスホジエステラーゼｉｖ阻害剤としての三置換フェニル誘導体
US5521813A (en) * 1993-01-15 1996-05-28 Strategic Weather Services System and method for the advanced prediction of weather impact on managerial planning applications
US5496826A (en) * 1994-09-02 1996-03-05 Bristol-Myers Squibb Company Pharmaceutical methods of using heterocyclic derivatives of N-phenylamides
US5821258A (en) * 1994-12-27 1998-10-13 Mitsui Chemicals, Inc. Phenylbenzimidazole derivatives
AU4988997A (en) * 1996-10-23 1998-05-15 Osteoscreen, Inc. Compositions and methods for treating bone deficit conditions
US6988076B2 (en) * 1997-05-21 2006-01-17 Khimetrics, Inc. Strategic planning and optimization system
CZ20004350A3 (cs) * 1998-05-22 2002-02-13 Avanir Pharmaceuticals Benzimidazolové deriváty jako modulátory IgE
US6910017B1 (en) * 1999-03-05 2005-06-21 Profitlogic, Inc. Inventory and price decision support
US6405175B1 (en) * 1999-07-27 2002-06-11 David Way Ng Shopping scouts web site for rewarding customer referrals on product and price information with rewards scaled by the number of shoppers using the information
US6546387B1 (en) * 1999-11-15 2003-04-08 Transcom Software Inc. Computer network information management system and method using intelligent software agents
US20020042739A1 (en) * 2000-03-13 2002-04-11 Kannan Srinivasan Method and system for creating and administering internet marketing promotions
US20020023001A1 (en) * 2000-07-11 2002-02-21 Mcfarlin James A. Method and apparatus for online creation and sale of custom local store marketing materials
EP1342199A1 (en) * 2000-11-15 2003-09-10 Manugistics Atlanta, Inc. Promotion pricing system and method
US20020198794A1 (en) * 2001-06-21 2002-12-26 Williams Edward P. Inventory management system for determining suggested part stocking levels for a vehicle dealer

Also Published As

Publication number Publication date
ZA200007754B (en) 2001-08-16
NO20005887D0 (no) 2000-11-21
UA67774C2 (uk) 2004-07-15
CN1219510C (zh) 2005-09-21
US6271390B1 (en) 2001-08-07
CN1311675A (zh) 2001-09-05
HUP0101894A3 (en) 2002-07-29
AU4094299A (en) 1999-12-13
AU754943B2 (en) 2002-11-28
CN1311679A (zh) 2001-09-05
US20020010343A1 (en) 2002-01-24
NZ508416A (en) 2004-01-30
JP2002516276A (ja) 2002-06-04
HUP0102550A2 (hu) 2001-10-28
DE69924607D1 (de) 2005-05-12
EP1077695A2 (en) 2001-02-28
EP1077700A1 (en) 2001-02-28
UA67775C2 (uk) 2004-07-15
ATE292465T1 (de) 2005-04-15
KR20010030179A (ko) 2001-04-16
CA2332999A1 (en) 1999-12-02
CA2332985A1 (en) 1999-12-02
RU2236220C2 (ru) 2004-09-20
IL139828A0 (en) 2002-02-10
EP1077700B1 (en) 2005-04-06
BR9910640A (pt) 2001-10-30
HUP0102128A2 (hu) 2002-03-28
ES2241285T3 (es) 2005-10-16
MXPA00011422A (es) 2002-12-13
NO20005888L (no) 2001-01-22
MXPA00011467A (es) 2002-10-17
WO1999061019A1 (en) 1999-12-02
CN1721411A (zh) 2006-01-18
NO20005889D0 (no) 2000-11-21
KR100591652B1 (ko) 2006-06-26
NZ508413A (en) 2003-08-29
MXPA00011470A (es) 2002-10-17
US6451829B2 (en) 2002-09-17
PL345560A1 (en) 2001-12-17
HUP0102128A3 (en) 2002-05-28
WO1999061013A3 (en) 2000-04-06
PL345952A1 (en) 2002-01-14
WO1999061013A2 (en) 1999-12-02
CN1317965A (zh) 2001-10-17
PL345219A1 (en) 2001-12-03
EP1079830A1 (en) 2001-03-07
BR9910642A (pt) 2001-10-09
CA2332989A1 (en) 1999-12-02
HUP0102550A3 (en) 2002-11-28
JP2002516274A (ja) 2002-06-04
BR9910641A (pt) 2001-10-02
CZ20004350A3 (cs) 2002-02-13
AU4312099A (en) 1999-12-13
IL139826A0 (en) 2002-02-10
AU4197899A (en) 1999-12-13
CZ20004351A3 (cs) 2001-10-17
NO20005888D0 (no) 2000-11-21
ZA200007753B (en) 2001-07-18
WO1999061020A1 (en) 1999-12-02
IL139827A0 (en) 2002-02-10
ZA200007752B (en) 2001-12-05
AU754562B2 (en) 2002-11-21
HUP0101894A2 (hu) 2002-02-28
NO20005889L (no) 2001-01-22
DE69924607T2 (de) 2006-02-02
RU2236221C2 (ru) 2004-09-20
JP2002516277A (ja) 2002-06-04

Similar Documents

Publication Publication Date Title
NO20005887L (no) Forbindelser med IgE-påvirkende egenskaper
MXJL03000027A (es) Compuestos de benzimidazol para modular la ige e inhibir la proliferacion celular.
BR0314235A (pt) Compostos de fenil-aza-benzimidazol para modulação de ige e inibição da proliferação celular
ATE389649T1 (de) Substituierte amin-derivate und deren verwendung zur behandlung von angionese-bedingten erkrankungen
DE60222671D1 (de) Thienopyrimidinedione und deren verwendung in der behandlung von autoimmunerkrankungen
ES2248356T3 (es) Compuestos para tratar la enfermedad de alzheimer.
DE60216122D1 (de) Cysteinprotease-hemmer mit 2-cyano-4-amino-pyrimidinstruktur und cathepsin-k-hemmender wirkung zur behandlung von entzündungen und anderen erkrankungen
DE60223715D1 (de) Glyt1 transporter inhibitoren und deren anwendung in der behandlung von neurologischen und neuropsychiatischen krankheiten
BR0316350A (pt) Diaminotriazóis úteis como inibidores de proteìna cinases
BR0107691A (pt) Sapogeninas substituìdas e seu uso
WO2004024896A3 (en) Phenyl-indole compounds
TW200503695A (en) Imidazole derivatives for treatment of allergic and hyperproliferative disorders
SE0302304D0 (sv) Novel compounds
DE602004009414D1 (de) BEHANDLUNG VON GASTROINTESTINALEN ERKRANKUNGEN MIT N-2,3,3-TETRAMETHYLBICYCLOi2.2.1öHEPTAN-2-AMINE
CY1106740T1 (el) Παραλλαγες του μειζονος αλλεργιογονου par j 2 του φυτου περδικακι
ATE295724T1 (de) Der duale inhibitor der cholesterylester und wachsester synthese avasimibe zur behandlung von erkrankungen des talgdrüse
DE60113535D1 (de) Kompositionen und verwendungen von cgi-69
SE9901273D0 (sv) Novel compounds
PT1032415E (pt) Prevencao e/ou tratamento de condicoes alergicas
DK0566592T3 (da) Pyrimido-benzothiaziner med lipoxygenasehæmmende virkning

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application